1 Exhibit 4.2 STOCK OPTION AGREEMENT STOCK OPTION AGREEMENT, dated as of April 1, 1996 (the "Effective Date") between Viragen (Europe) Ltd., a Delaware Corporation (the "Company") and Donald Magnus Nicolson ("Optionee"). The Company, hereby grants to...Stock Option Agreement • March 15th, 2000 • Viragen Europe LTD • Biological products, (no disgnostic substances) • Delaware
SERIVE AGREEMENT BETWEEN VIRAGEN (SCOTLAND) LIMITED AND DONALD MAGNUS NICOLSON I refer to the above Service Agreement ("the Agreement") dated 16th and 19th February, 1996, which is amended as follows:- 1. In respect of the Term clause 4.3 of the...Service Agreement • October 1st, 1997 • Viragen Europe LTD • Biological products, (no disgnostic substances)
EXHIBIT 2(b) AMENDMENT TO AGREEMENT AND PLAN OF REORGANIZATION Amendment ("Amendment") to Agreement and Plan of Reorganization entered into as of November 8, 1995 by and among Sector Associates, Ltd., a Delaware corporation ("Acquiror"), Viragen...Agreement and Plan of Reorganization • December 21st, 1995 • Sector Associates LTD • Retail-furniture stores • Florida
RECITALSTermination Agreement • November 19th, 2001 • Viragen Europe LTD • Biological products, (no disgnostic substances) • Florida
1 Exhibit 4.7 2 EXHIBIT 4.7 SECTOR ASSOCIATES, LTD. Securities Purchase Agreement Units consisting of ten (10) shares of Common Stock and Thirty-Five (35) Common Stock Purchase Warrants offered at $2.23 per Unit...Securities Purchase Agreement • December 7th, 1995 • Sector Associates LTD • Retail-furniture stores • Delaware
1 EXHIBIT 10.13 THIS AGREEMENT is made the 15th day of February 2001 BETWEEN VIRAGEN, INC. and its subsidiary, VIRAGEN (SCOTLAND) LIMITED ("Viragen"), Pentlands Science Park, Bush Loan, Penicuik, Midlothian, EH26 0PZ, Scotland AND PENG LEE YAP, M.D.,...Consulting Agreement • September 28th, 2001 • Viragen Europe LTD • Biological products, (no disgnostic substances)
1 EMPLOYMENT AGREEMENT -------------------- AGREEMENT dated as of March 1, 1997 (the "Effective Date") by and between VIRAGEN (EUROPE) LTD., a Delaware corporation ("Employer or the "Company"), and GERALD SMITH ("Employee"). W I T N E S S E T H: - - -...Employment Agreement • October 1st, 1997 • Viragen Europe LTD • Biological products, (no disgnostic substances) • Florida
RECITALSLicense Agreement • April 7th, 1999 • Viragen Europe LTD • Biological products, (no disgnostic substances) • Florida
1 EMPLOYMENT AGREEMENT -------------------- AGREEMENT dated as of March 1, 1997 (the "Effective Date") by and between VIRAGEN (EUROPE) LTD., a Delaware corporation ("Employer or the "Company"), and DENNIS W. HEALEY ("Employee"). W I T N E S S E T H: -...Employment Agreement • October 1st, 1997 • Viragen Europe LTD • Biological products, (no disgnostic substances) • Florida
1 Exhibit 10-(v) ADDENDUM TO EMPLOYMENT AGREEMENT BETWEEN VIRAGEN (EUROPE) LTD. (EMPLOYER) AND DENNIS W. HEALEY (EMPLOYEE) It is agreed by Employer and Employee that the Employment Agreement between Employer and Employee dated March 1, 1997 be amended...Employment Agreement • April 7th, 1999 • Viragen Europe LTD • Biological products, (no disgnostic substances)
1 EXHIBIT 10.16 EMPLOYMENT AGREEMENT AGREEMENT dated 1st July 2001 (the "Effective Date") by and between VIRAGEN (SCOTLAND) LIMITED, a company registered in Scotland with registered number 155387 and having a place of business at Pentlands Science...Employment Agreement • September 28th, 2001 • Viragen Europe LTD • Biological products, (no disgnostic substances)
EXHIBIT 10.22 ----------------------------------------------------------------- --------------- SUPPLY AND DISTRIBUTION AGREEMENT ----------------------------- --------------------------------------------------- 1. PARTIES This Agreement is made...Supply and Distribution Agreement • May 14th, 2003 • Viragen International Inc • Biological products, (no disgnostic substances)
SUPPLY AND DISTRIBUTION AGREEMENTSupply and Distribution Agreement • February 14th, 2003 • Viragen International Inc • Biological products, (no disgnostic substances)
1 EXHIBIT 10.(ix) VIRAGEN TECHNOLOGY, INC. 865 SW 78TH AVENUE, SUITE 100 PLANTATION, FL 33324 PHONE: (954) 233-8746 FAX: (954) 233-1412 September 29, 1997 Viragen (Scotland) Ltd. 2343 West 76th Street Hialeah, FL 33016 RE: LICENSING AGREEMENT DATED...Licensing Agreement • April 7th, 1999 • Viragen Europe LTD • Biological products, (no disgnostic substances)
SUBSCRIPTION AGREEMENTSubscription Agreement • July 28th, 2006 • Viragen International Inc • Biological products, (no disgnostic substances) • Florida
THIS SUBSCRIPTION AGREEMENT (this “Agreement”) dated as of July , 2006, by and among VIRAGEN INTERNATIONAL, INC., a Delaware corporation (the “Company”), and the subscribers identified on the signature page hereto (each a “Subscriber” and collectively “Subscribers”).
SUBSCRIPTION AGREEMENTSubscription Agreement • August 23rd, 2006 • Viragen International Inc • Biological products, (no disgnostic substances) • Florida
Safety Agreement Viragen International, Inc. Swedish Orphan InternationalSafety Agreement • April 19th, 2007 • Viragen International Inc • Biological products, (no disgnostic substances)
Technical Agreement Viragen Orphan AustraliaTechnical Agreement • December 28th, 2006 • Viragen International Inc • Biological products, (no disgnostic substances)
LICENSE AGREEMENTLicense Agreement • December 28th, 2006 • Viragen International Inc • Biological products, (no disgnostic substances) • Delaware
This Agreement is made effective on December 22, 2006 by and between Viragen International, Inc., a company incorporated in Delaware, USA with its principal offices located at 865 SW 78th Avenue, Plantation, Florida, USA, and its Affiliates and Subsidiaries (VGN) and Orphan Australia Proprietary Limited, a company incorporated in Victoria, Australia with its principal offices located at 48 Kangan Drive, Berwick Victoria 3806, Australia, and its Affiliates and Subsidiaries (OA);
1 EXHIBIT 10.(vi) INDEMNIFICATION AGREEMENT ------------------------- For good and valuable consideration, the receipt of which is hereby acknowledged, including the willingness and commitment of the indemnitee identified below to enter into and...Indemnification Agreement • April 7th, 1999 • Viragen Europe LTD • Biological products, (no disgnostic substances)
Re: Selling Agreement (the “Agreement”)Selling Agreement • July 28th, 2006 • Viragen International Inc • Biological products, (no disgnostic substances) • Florida
Viragen International, Inc., a Delaware corporation (the “Seller”), proposes to offer and sell (the “Offering”), to selected investors, upon the terms set forth herein and in the Securities Purchase Agreement and other documents to be supplied to the investors (which collectively, together with the attachments and exhibits thereto, is referred to as the “Offering Document”), a copy of which has been delivered to you, up to 18,000 units (the “Units”) at a price per Unit of $100; with each Unit consisting of one share of Series C 24% Cumulative Preferred Stock and 200 shares of common stock of Viragen International, Inc. The convertible preferred shares have a dividend of 24% per annum payable annually and are redeemable by either the investor or the Company under certain conditions (the “Preferred Stock”). See the Term Sheet attached hereto as Exhibit A for additional detail. (The Units are sometimes referred to hereafter as the “Offered Securities”). Dawson James Securities, Inc. (the
Technical Agreement Viragen International Swedish Orphan InternationalTechnical Agreement • April 19th, 2007 • Viragen International Inc • Biological products, (no disgnostic substances)
ANDERSEN LEGAL HAKAN BORG AND OTHERS VIRAGEN (EUROPE) LIMITED AND VIRAGEN INC. AGREEMENT FOR THE ACQUISITION OF BIONATIVE AB DATED 28th SEPTEMBER 2001 TABLE OF CONTENTSAgreement for the Acquisition of Bionative Ab • September 28th, 2001 • Viragen Europe LTD • Biological products, (no disgnostic substances)
LICENSE AGREEMENTLicense Agreement • April 19th, 2007 • Viragen International Inc • Biological products, (no disgnostic substances) • Delaware
This Agreement is made effective on April 16, 2007 by and between Viragen International, Inc., a company incorporated in Delaware, USA with its principal offices located at 865 SW 78th Avenue, Plantation, Florida, USA, and its Affiliates and Subsidiaries (VGN) and Swedish Orphan International, a company incorporated in Sweden with its principal offices located at Drottninggatan 98, 111 60 Stockholm, Sweden and its Affiliates and Subsidiaries (SOI).
Safety Agreement Viragen Orphan AustraliaSafety Agreement • December 28th, 2006 • Viragen International Inc • Biological products, (no disgnostic substances)
1 EXHIBIT 10.11 THIS AGREEMENT is made the 8th day of January 2001 BETWEEN VIRAGEN (SCOTLAND) LIMITED, Pentlands Science Park, Bush Loan, Penicuik, Midlothian, EH26 0PZ, Scotland AND PETER COOPER ASSOCIATES, Cheviot Lodge, Bemersyde, Melrose,...Consulting Agreement • September 28th, 2001 • Viragen Europe LTD • Biological products, (no disgnostic substances)
SUBSCRIPTION AGREEMENTSubscription Agreement • October 6th, 2006 • Viragen International Inc • Biological products, (no disgnostic substances) • Florida
